FDA Drug · D-1484-2020

Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, Rockford, IL 61103 USA, NDC 67457-813-50

Class I · Terminated

Presence of Particulate Matter

Affected lots / codes — check yours against thisLot #: 7605112, Exp 10/2021

Recalling firm: Mylan Institutional LLC, Rockford, IL
Classification: Class I (most serious — risk of serious harm)
Status: Terminated
Quantity: 18,480 vials
Distribution: USA Nationwide
Recall initiated: July 7, 2020
Classified: August 4, 2020
Terminated: January 27, 2023
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1484-2020%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →